Clinical manifestations, pathology, and pathogenesis of kidney disease are complex and diverse. They are easier to understand when divided into separate clinicopathologic entities on the basis of the renal structures (glomerulus, tubules, interstitium, and blood vessels) that are the primary targets of injury (1) . Great progress in our knowledge of kidney disease has also been achieved through clinical and experimental studies that have revealed some of the immunologic mechanisms involved in renal diseases. For the benefit of readers with little knowledge of kidney pathology, I will first summarize in a schematic fashion the major immunemediated kidney disorders (Table 1) .
Kidney disease can be the result of glomerular and/or tubulointerstitial injury due to one or more of the following basic tissue reactions.
Inflammation (influx ofleukocytes) in the glomerulus. Inflammation (influx of leukocytes) in the glomerulus causes a nephritic (glomerulonephritic) syndrome with increased permeability to red cells (hematuria) as well as decreased glomerular filtration rate (leading to increased blood urea nitrogen and creatinine). The glomerulus is also more permeable to proteins, which results in mild to severe proteinuria. There are various types of glomerulonephritis. Acute endocapillary glomerulonephritis is characterized by abrupt onset of renal dysfunction with hematuria of glomerular origin. Glomerular hypercellularity, composed of inflammatory cells and proliferating mesangial and endothelial cells, is the most important pathologic lesion (2) . The prototype of this condition is poststreptococcal glomerulonephritis, but it has also been observed in other infectious diseases and in some patients with systemic lupus erythematosus (SLE) (3) . Crescentic glomerulonephritis, also called rapidly progressive glomerulonephritis, causes hematuria and a rapid, progressive dedine in glomerular filtration rate (4, 5) . Its pathology is characterized by glomerular inflammation, necrosis, and proliferating glomerular epithelial cells with formation of crescents occupying Bowman's spaces (6, 7) . Its (8) .
Thickening ofglomerular basement membranes. Thickening of glomerular basement membranes (GBMs), another basic tissue reaction affecting glomerular filtration, causes the nephrotic syndrome characterized by increased glomerular permeability with massive leakage of albumin (proteinuria, more than 3.5 g/day), hypoalbuminemia, and edema (9, 10) . It occurs in a pure nephrotic form (bland urine sediment, i.e., only albumin and no red cells) in patients with minimalchange disease or membranous nephropathy. The histopathology of minimal change disease shows a paucity of glomerular changes by light microscopy (11) (12) (13) . Similarly, there are no detectable immune deposits by immunofluorescence. However, electron microscopy reveals effacement of podocyte foot processes, swelling of endothelial cells, and occasionally small subendothelial deposits. The pathogenesis of this condition is uncertain, but immunologic mechanisms may be involved (11, 14) . Membranous nephropathy, also called membranous glomerulonephropathy or membranous glomerulonephritis, is characterized by thickening of glomerular capillary walls and absence of inflammatory cells. Granular deposits of immunoglobulins and subepithelial electron-opaque deposits are present in the GBM (15) (16) (17) . In addition, thin argyrophilic projections (spikes) arise from the lamina densa of the GBM. A mixed nephrotic/nephritic form of the nephrotic syndrome (with active urine sediment, i.e., hematuria and proteinuria) occurs in patients with mesangiocapillary glomerulonephritis, also called membranoproliferative glomerulonephritis, (18) (19) (20) (21) Tubulointerstitial syndromes. Inflammation of tubules and interstitium with relative sparing of glomeruli causes acute or chronic tubulointerstitial syndromes with defects in tubular function (25, 26) . Acute tubulointerstitial nephritis is characterized by a sudden clinical onset, decrease in renal function, fever, and hematuria. There is renal interstitial edema, leukocytic infiltration, and focal tubular necrosis (27) . Chronic tubulointerstitial nephritis is distinguished by polyuria, nocturia, and mild proteinuria. Its histopathology shows mononuclear cell infiltration and fibrosis of the renal interstitium as well as tubular atrophy. Both acute and chronic tubulointerstitial nephritis are caused by reactions to certain drugs, infections, and/or immune mechanisms (25) . Either form can be observed in kidneys of some patients with SLE, where interstitial inflammation may be predominant over the glomerular lesions.
Immunologically mediated injury is a common pathogenesis of the kidney disorders summarized above (28) (29) (30) (31) (32) (37, 38) . Less recognized is the possible role of xenobiotics as inducers of autoimmunity (39) .
Xenobiotics are foreign substances of synthetic, natural, or biologic origin that can affect the immune system and cause either immunosuppression or allergic and autoimmune responses (39) (40) (41) (42) (43) (44) (45) (46) (47) (48) (49) (50) (Table 2) . A second group of immunotoxic metals, induding cadmium, chromium, copper, lead, platinum, and zinc, has only occasionally been associated with autoimmunity (Table 2) (44) .
Gold-induced Renal Autoimmunity
Gold has been recently described as "possibly the most ancient and ... one of the most modern agents in all of medicine's pharmacopoeia" (96) . It has also become one of the most common allergens and in some countries is second only to nickel in the etiology of cutaneous hypersensitivity reactions (97) . In spite of these immunotoxic effects, environmental or occupational exposure to gold does not seem to cause major renal pathology. Workers employed in gold mining and refining as well as goldsmiths and neighbors of gold shops in the Amazon are more likely to show evidence of mercury, not gold, contamination (98) . However, a recent report of rapidly progressive interstitial lung fibrosis (Hamman-Rich syndrome) in a goldsmith has raised the possibility that occupational exposure to this metal may occasionally have pathologic consequences (99) . This is suggested by the occurrence of interstitial lung fibrosis, possibly with an autoimmune pathogenesis, as a rare complication of treatment with gold compounds (100) .
The medical literature contains numerous reports of human disease from therapy with gold salts, self-administration of folk remedies containing gold, or the ingestion of liquor containing this metal (101) (102) (103) (104) (105) . Since 10 reacted only with Ro 60 kD, and a third group reacted with all three antigens. The first group had severe skin eruptions, the second group had either proteinuria and/or leukopenia, and the third group had Sjogren's syndrome (80) . Thrombocytopenia has also been observed in 1-3% of patients treated with gold salts (81, 116, 117 ). An association with HLA-DR3 and the presence of autoantibodies against platelet epitopes suggest the importance of immunologic mechanisms: platelet destruction may be mediated by these autoantibodies, either acting alone or in combination with gold (81, 118) .
Numerous reports ofgold therapy followed by renal lesions can be found in the literature of the 1960s and 1970s (85, (119) (120) (121) . Proteinuria was detected in 6-17% and a nephrotic syndrome in 2.6-5.3% of RA patients treated with gold salts (86) . The relative risk of proteinuria during gold treatment of RA was increased 32 times in patients who were HLA-DR3 positive (122) (123) (124) (125) . A survey of 122 RA patients who underwent kidney biopsy after the development of proteinuria showed that 41% of these subjects presented with a nephrotic syndrome. Membranous glomerulonephropathy was present in 89.5% and minimal change nephropathy in 9.6% (86, 126, 127) . Such adverse effects of gold therapy are still occurring, as shown by a recent report of a patient affected by psoriatic arthritis who after 3 years of oral gold therapy developed membranous glomerulonephropathy, autoantibodies to myeloperoxidase, and vasculitis (128) . It should be noted that there are dose similarities between gold and penicillamine nephropathy (127) . Finally, in view of the recent popularity of food supplements and folk medicines, often imported from overseas without a controlled designation of their composition, it is of interest that an oral tonic containing gold (known as Gold Kushta) has been associated with a nephrotic syndrome in some subjects (101) and that lichenoid dermatitis has been diagnosed in three patients who had consumed an alcoholic beverage containing gold (105) .
Autoimmunity Induced by Gold in Experimental Animals
Early studies performed in outbred Wistar rats showed that injection ofsodium aurothiomalate (0.025 mg once a week) caused proteinuria after 7 weeks of treatment (129) . Kidney histopathology and immunohistopathology revealed diffuse thickening of glomerular capillary walls as well as granular glomerular deposition of rat immunoglobulins and complement. Electron microscopy showed electron-opaque deposits along the epithelial aspect of the renal GBM and loss of epithelial foot processes. Gold was detected only in proximal convoluted tubules. Rabbits fed flour containing an indigenous preparation of gold oxide (Gold Kushta) or injected with sodium aurothiomalate developed proteinuria as well as thickening of glomerular basement membranes and electron-opaque deposits (101) . Similar effects followed the subcutaneous administration of sodium aurothiomalate to guinea pigs, with proteinuria, renal lesions, and immune complex nephropathy (130) . Light microscopy revealed two different histopathology patterns. The first, characterized by interstitial mononuclear cell infiltration, tubular destruction, and interstitial fibrosis, was associated with the production of autoantibodies to tubular basement membranes. The second consisted of thickening of glomerular capillary walls and mesangial cellularity. It was associated with the production of autoantibodies to renal epithelial antigens and the glomerular deposition of granular immune complexes containing renal antigens and their specific autoantibodies.
These initial studies, performed in outbred animals and lacking the more sophisticated reagents and methods currently available, are still of some value because they demonstrate that different animal species are susceptible to gold-induced autoimmune effects similar to those experienced by humans. More recent studies have provided additional details on the pathogenesis of renal autoimmune disease caused by exposure to gold. Inbred mice of the A.SW strain (H-2S) treated with gold sodium thiomalate produce autoantibodies to nucleolar antigens (131, 132) . Because the immunofluorescence pattern produced by these autoantibodies is similar to that observed in H-2S mice injected with mercury, it is likely that the autoantigen involved is fibrillarin (see "Mercury-Induced Renal Autoimmunity'). Mice of this strain develop elevated levels of serum IgE, IgG, and IgM after 8 weeks of gold treatment (133) . The oxidation state of gold, i.e., Au(III) versus Au(I), seems to play a major role in the immunotoxicity of this metal and its induction ofautoimmune responses (132) .
Brown Norway (BN) rats treated with gold salts develop autoimmunity (83, 84) . Autoantibodies reacting with the renal GBM, and in particular with laminin 1 (a component of the extracellular matrix), were found in all animals injected with aurothiopropanolsulfanate (84) . Other autoantibodies (against nuclear antigens, double-stranded DNA, thyroglobulin, actin, myosin, and tubulin) were detected in gold-treated BN rats. In addition, serum IgE levels increased and showed a first peak at the end of the first week of gold treatment and a second, higher peak at the end of the third week. After 4 weeks, intense linear IgG deposits were present along the GBM and tubular basement membrane (TBM). Indirect immunofluorescence showed that eluates from these deposits reacted in vitro with GBM and TBM. Glomerular linear and/or granular deposits were also observed after 8 weeks of gold treatment. Light microscopy and electron microscopy showed that kidneys were normal after 4 weeks. Diffuse interstitial mononuclear cell infiltrates and small electron-opaque mesangial and subepithelial deposits were present after 8 
Mercury-induced Renal Autoimmunity
Mercury is a xenobiotic widely present in the environment. Its levels are increasing as a consequence of the processing of raw ores, various industrial activities, and the discharge of medical and scientific waste (44, 98) . One of the major routes of human exposure to mercury may currently be the ingestion of contaminated food, especially fish (135) . The potential health risks of mercury released from dental amalgam fillings are still a source of controversy (74, 136, 137) . Finally, a possible new source of mercury exposure may be unregulated dietary supplements and health remedies that contain other metals such as silver and gold (101, 138 The various cellular components of the immune system can be activated or inhibited by low levels of mercury (Table 3) (44, 49, (139) (140) (141) proliferation and decreased production of IL-2 has been observed in human T cells treated in vitro with HgCl2. In vivo exposure to mercury increases T-lymphocyte responses in BALB/c mice and decreases them in Swiss and (B6 x C3)F, hybrid mice. Mercury also causes both apoptosis and necrosis of various T-cell lines (142, 143) . Spleen cell cultures from HgCl2-treated BN rats exhibit a marked decrease in the concanavalin A-induced generation of interferon (IFN)-y--producing cells, an inhibition likely caused by nitric oxide (144, 145) .
Early studies showed that human B cells treated with HgCl2 and pokeweed mitogen were stimulated to produce IgE (150) . However, more recent investigations have demonstrated that exposure to HgCl2 in vitro may result in a dose-dependent inhibition of human B-cell proliferation and immunoglobulin yield (163) . Similarly, murine B cells treated in vitro with mercury exhibit inhibition of both RNA and DNA synthesis and significant decreases in production of immunoglobulin isotypes (152) . On the other hand, B lymphocytes from mercury-treated rats and mice are stimulated to produce IgE and other immunoglobulin isotypes (149, 151, 153, 154) . Investigations of mercury effects on macrophages have detected inhibition ofphagocytosis and free radical production. Depending on its in vitro concentration, HgCl2 stimulates H202 release from Lewis (LEW) but not BN macrophages and can inhibit phagocytosis in both LEW and BN resident peritoneal macrophages (155) . Finally, treatment with HgCI2 induces IL-1 production by murine macrophages (156) and higher gene expression of IL-12 in spleen cells of LEW rats (164) . Studies of the effects of mercury on human PMN are quite sparse. Concentrations of HgCl2 between 1 pM and 0.01 fM inhibited adherence, polarization, chemotaxis, and erythrophagocytosis of human PMN (157) . In addition, 1 nM to 1 fM HgCl2 significantly stimulated H202 production and chemiluminescence of these cells. Inhibition of microbicidal activities and respiratory burst, decreased superoxide anion formation, and chemotaxis have also been detected after exposure to methyl mercury, mercuric chloride, and silver lactate (158, 165, 166 following the introduction of powerful nonmercurial diuretics and antiseptics. When drugs containing mercury were commonly used, they often caused autoimmune disease (Table 4) .
Several instances of mercury-associated nephrotic syndrome after treatment with organomercurial diuretics for congestive heart failure, ingestion of mercury-containing laxatives, or the protracted use of ammoniated mercury in skin ointments for the treatment of psoriasis have been reported in the literature (86) . A nephrotic syndrome associated with the use of skin-lightening creams containing mercury was also observed in numerous East African patients (87, 89) . Direct immunofluorescence showed that IgG and complement were bound at the level of the renal GBM in kidney biopsies from these patients. The nephrotic syndrome resulting from treatment with mercury was due to renal histopathologic lesions defined as membranous glomerulonephritis, membranous nephropathy, or membranous glomerulonephropathy (15) (16) (17) . The lack of inflammatory changes at the glomerular level suggests that the two latter terms may be more appropriate. As noted in a recent textbook of general pathology, "the suffix -itis usually means inflammation of that organ or tissue (appendic-itis, mening-itis, pleur-itis)" (168) . The presence of glomerular immune deposits cannot be considered equivalent to an ongoing inflammatory process, as antibody-mediated damage may occur without the presence of neutrophils, lymphocytes, and/or macrophages in the target tissues (29, 169, 170) .
Occupational exposure to mercury does not usually result in autoimmune responses and disease (58, 59) . Early reports that workers in mercury-producing industry developed circulating antilaminin antibodies have not been confirmed (58, (171) (172) (173) . However, one cohort of workers exposed to mercury had a slight increase in autoantibodies to DNA (58) . This observation may be of some interest, a few subjects with industrial exposure to mercury have also developed antinuclear antibodies, sclerodermalike disease, lichen planus, or membranous nephropathy (91, 92, 167) .
Thus, when one examines the relevant literature, it is evident that mercury can cause autoimmune responses and disease in humans (Table 4) , even if changes in therapeutics have obviously led to a decrease of these effects. However, the risk of autoimmune consequences continues to be present because mercury is currently used as a preservative in some immunoglobulin and vaccine preparations, and may be a contaminant of fish (135), imported food supplements, and unregulated health remedies. An additional but still controversial source ofvery low levels of mercury is provided by dental amalgam (74, 136, 137, 174) . Clearly, it is quite difficult to study in human subjects the autoimmune effects of the chronic exposure to very low levels of mercury, either alone or in association with other xenobiotics. These difficulties are not encountered when using experimentally induced models ofautoimmune disease that provide the opportunity ( (187, 188) .
The kidneys of mercury-treated inbred (SJL, ASW, BALB/c) and outbred ICR mice contain granular immune deposits, mostly localized in the glomerular mesangium and the walls of interlobular arterioles and arteries (178) . Interestingly, mice of the A.CA/SnJ, DBA/lJ, and P/J strains that also produce antifibrillarin autoantibodies do not show renal immune deposits, for reasons that are (190, 191 (192, 203 Eluates from these deposits contain autoantibodies to laminin 1, whereas C3 is usually undetectable. Linear deposits of IgG (likely containing the same autoantibodies) are present in basement membranes of spleen, liver, adrenals, and heart (44, 205) . Similar linear deposits of IgG are also found in basement membranes of the intestine after oral administration or subcutaneous injection of HgCl2 (44, 206 (29) . An alternative cause of proteinuria in DZB and PVG rats with renal immune deposits containing complement components is the activation of the classical complement pathway.
The histopathology of the renal damage caused by mercury-induced autoimmunity in BN, MAXX, and DZB rats is characterized by rather minor changes. An early publication reported various numbers of large mononuclear cells in glomeruli and focal detachment of glomerular endothelial cells as well as subendothelial and scattered subepithelial deposits (207) . In our experiments with BN rats, the most prominent and frequent lesion was the detachment of endothelial cells from the GBM (208) . Electron-opaque material, loose to compact floccular, was often present in the spaces created by the uplifting of the endothelial cells. These changes were observed in kidneys obtained on day 15 and day 30 of mercury treatment but were more pronounced in the latter. Occasionally, there was mesangial expansion of peripheral capillary loops with resulting splitting. Rare capillary loops showed small subepithelial electronopaque deposits. To obtain more precise morphologic information, we examined kidneys from mercury-treated MAXX rats after in vivo perfusion with glutaraldehyde (192 (209) . The numbers of thymus cells and the percentage of CD8+CD4+ double-positive thymocytes decreases, whereas the percentage of singlepositive CD8+ or CD4+ and double-negative CD8-CD4-thymocytes increases (209) . Total numbers of double-positive CD8+CD4+ thymocytes decrease, but total numbers of CD4+ single-positive thymocytes increase. We have also observed that HgC12-treated BN rats have a decrease of RT6+ T cells (202, 210) . Kinetic studies of this change have shown significant percentage decreases after 8, 1 1, and 15 days of HgCl2 treatment and an inverse correlation with autoimmune responses to laminin 1 (Figure 1 ). Two-color flow cytometry has revealed that percentages of both RT6.2+CD4+ and RT6.2+CD8+ T lymphocytes decrease on day 15 of mercury treatment (202) . Studies of diabetes-prone BB rats have suggested that RT6+ T cells may have a still unexplained immunoregulatory role (211) (212) (213) (214) .
As previously mentioned, the histopathology observed by most investigators of this rat model is a membranous glomerulonephropathy without evident lesions in other tissues. More recently, inflammatory processes in various organs and tissues of mercury-treated BN rats have been reported. Inflammation and ulceration of the skin, hepatic periportal mononuclear cell infiltrates, and hemorrhagic lesions of the gut with intense submucosa inflammation and leucocytoclastic vasculitis have been observed (215) (216) (217) (218) (219) . These rats produce antibodies to myeloperoxidase and develop a CD8+ T-lymphocyte-mediated inflammatory polyarthritis. A focal inflammatory process of the parotid, submandibular, and lachrymal glands similar to the lesions of Sjogren's syndrome has also been detected in HgC12-treated BN rats (220, 221) . Because we had never observed any of these lesions, we recently re-examined a variety of tissues from various groups of BN rats injected with mercury. In spite of a very careful examination of plastic-embedded toluidine blue-stained sections as well as paraffin-embedded H&E-stained sections, we have not been able to detect inflammatory changes in thyroid, pancreas, intestine, skin, liver, parotid, and lung (44) . At present, we cannot explain the difference in histopathology between our BN rats and those examined by other investigators. However, it has been reported that the inflammatory changes observed in various tissues disappear after antibiotic treatment, which suggests possible synergistic effects of mercury and microorganisms in rats that are not specific pathogen-free (218) .
Cytokine profiles obtained using quantitative and semiquantitative PCR have suggested the hypothesis that an imbalance between Thelper (Th) 1 and Th2 cells might be the basis of mercury-induced autoimmunity (45, 46 (193, 201, 202 (192, 222) . Most other inbred rat strains, with the LEW (RT-11 haplotype) as the prototype, are resistant to these autoimmune effects (222) . Particularly relevant in this regard are the findings in mercury-treated BN.1L and LEW.IN rats (i.e., animals that are congenic between the responder BN and the resistant LEW). None of these rats exhibit autoimmune responses to laminin, renal immune deposits, or proteinuria (204, 223) . On the other hand, circulating autoantibodies to laminin and IgG deposits in renal GBM can be induced by exposure to mercury in BN-*LEW.1N chimeras (223) . This demonstrates that both MHC and non-MHC background genes must be present for the induction of autoimmunity by mercury.
Finally, an interesting aspect of mercury immunotoxicity are the suppressive effects of this metal on autoimmune disease experimentally induced in LEW rats. Mercury inhibits experimental Heymann's nephritis, autoimmune encephalomyelitis, and autoimmune uveitis in LEW rats. This suppression may occur through the stimulation of non-antigenspecific CD8+ "suppressor/cytotoxic cells" T lymphocytes (199) , a lack of balance between Thl and Th2 cytokines (47) , or the secretion oftransforming growth factor-,B by autoreactive anti-class II CD4+ T cells (224) . We have recently demonstrated that mercury had no inhibitory effects on the spontaneous development and progression of insulin-dependent diabetes mellitus and thyroiditis in diabetes-prone BB rats (197) (227) . There are also notable clinical and laboratory discrepancies between drug-related lupus and SLE (227, 228) . On the contrary, autoimmune diseases induced by penicillamine (SLE, pemphigus, myasthenia gravis) are identical or quite similar to the corresponding idiopathic disorders (42) . Gold (233) . As mentioned at the beginning of this review, SLE is characterized by a wide spectrum of renal pathologic changes, from mesangial and membranous nephropathy to severe glomerulonephritis, often leading to sclerosing nephropathy (23, 234, 235) . Renal manifestations in patients with systemic sclerosis are caused by arterial and glomerular lesions, with fibrinoid necrosis and fibrotic changes (236) . In contrast, the renal histopathology observed in rat models of mercury autoimmunity shows scarce alterations of kidney structures, lacks major inflammatory reactions, and is usually defined as a membranous nephropathy, not a glomerulonephritis (201) . Similarly, both immunohistopathology and histopathology of mercury-induced autoimmunity in SJL mice reveal immune deposits at the mesangial level, expanded glomerular mesangial zones with electron-opaque deposits, and a moderate increase of endocapillary cells (178, 188) . The absence of inflammatory or other major structural changes suggests that this pathology is best described by the term mesangial glomerulonephropathy.
In both rats and mice, mercury treatment causes a nephrotic syndrome, i.e., abundant proteinuria. BN, MAXX, and DZB rats produce autoantibodies against laminin 1 (148) . In this view, mercury would cause a lack of balance between Thl and Th2 cells (45, 46, 93, 238) . However, recent experiments in cytokine-knockout mice treated with mercury have not confirmed this hypothesis and have shown that IL-4 is not required, whereas IFN-y is essential for the production of autoantibodies to fibrillarin (239) . IFN-y may be necessary to stimulate immune responses to self-antigens, possibly through the increase in MHC class II and class I expression (facilitating epitope presentation) and/or the induction of costimulatory factors. Once autoimmunity is initiated, it may eventually develop in type 2 and/or type 1 cytokine-regulated responses, depending on cytokine level and balance, costimulatory molecules, autoantigen structure, and concentration and other environmental factors.
In conclusion, a single mechanism is unlikely to be responsible for the induction of autoimmune responses and disease by metals. Studies of these complex events are obviously difficult and may only be helped by in-depth investigations of animal models, that allow better control of some variables involved in the autoimmune process. Because of its diverse immunotoxic properties, mercury should be considered a paradigm of metalinduced autoimmunity (44) . In vitro and in vivo research of autoimmune disease caused by mercury, gold, and other metals has already yielded extremely valuable information and answered a number of important questions. At the same time it has raised various issues about possible immunostimulatory or immunosuppressive mechanisms of xenobiotic activity. Thus it is evident that investigations of metal-induced autoimmunity have the potential to produce new knowledge with relevance both to autoimmune disease caused by xenobiotics in general and to idiopathic autoimmunity.
